Press Releases Latest Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment Press Releases Year None202420232022202120202019201820172016201520142013 Apr 03, 2013 Renegotiated Lease to Generate Substantial Annual Savings Mar 25, 2013 Health Canada Decision Appealed Mar 04, 2013 Health Canada Issues Decision on Tesamorelin Feb 27, 2013 Theratechnologies Announces Financial Results for Fiscal Year 2012 Feb 14, 2013 Theratechnologies to Announce Financial Results for Fiscal Year 2012 Feb 05, 2013 Theratechnologies Announces Completion of NASDAQ Delisting Jan 29, 2013 Theratechnologies Secures US Patent for its Novel Peptide TH1173 Jan 21, 2013 FDA approves alternative storage conditions for EGRIFTA™ Jan 14, 2013 Theratechnologies Announces Intent to Voluntarily Delist from NASDAQ First page « Previous page ‹ … Page 30 Page 31 Page 32 Page 33 Page 34 Page 35 Page 36 Page 37 Current page 38 Displaying 371 - 379 of 379
Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment
